vs
Side-by-side financial comparison of LifeStance Health Group, Inc. (LFST) and PicoCELA Inc. (PCLA). Click either name above to swap in a different company.
LifeStance Health Group, Inc. is the larger business by last-quarter revenue ($382.2M vs $252.6M, roughly 1.5× PicoCELA Inc.). LifeStance Health Group, Inc. runs the higher net margin — 3.1% vs -125.2%, a 128.3% gap on every dollar of revenue. LifeStance Health Group, Inc. produced more free cash flow last quarter ($46.6M vs $-256.6M).
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
PicoCELA Inc. is a global technology company specializing in low-power, high-reliability wireless connectivity solutions, including Wi-Fi HaLow modules and edge network infrastructure. It caters to industrial IoT, smart city, retail, and smart home segments, with a primary operational footprint across Asia, North America, and European markets.
LFST vs PCLA — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $382.2M | $252.6M |
| Net Profit | $11.7M | $-316.2M |
| Gross Margin | — | — |
| Operating Margin | 4.7% | -114.8% |
| Net Margin | 3.1% | -125.2% |
| Revenue YoY | 17.4% | — |
| Net Profit YoY | 264.1% | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $382.2M | — | ||
| Q3 25 | $363.8M | — | ||
| Q2 25 | $345.3M | — | ||
| Q1 25 | $333.0M | $252.6M | ||
| Q4 24 | $325.5M | — | ||
| Q3 24 | $312.7M | — | ||
| Q2 24 | $312.3M | — | ||
| Q1 24 | $300.4M | — |
| Q4 25 | $11.7M | — | ||
| Q3 25 | $1.1M | — | ||
| Q2 25 | $-3.8M | — | ||
| Q1 25 | $709.0K | $-316.2M | ||
| Q4 24 | $-7.1M | — | ||
| Q3 24 | $-6.0M | — | ||
| Q2 24 | $-23.3M | — | ||
| Q1 24 | $-21.1M | — |
| Q4 25 | 4.7% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | -0.9% | — | ||
| Q1 25 | 0.5% | -114.8% | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | -5.1% | — | ||
| Q1 24 | -5.6% | — |
| Q4 25 | 3.1% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | -1.1% | — | ||
| Q1 25 | 0.2% | -125.2% | ||
| Q4 24 | -2.2% | — | ||
| Q3 24 | -1.9% | — | ||
| Q2 24 | -7.5% | — | ||
| Q1 24 | -7.0% | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $248.6M | $456.8M |
| Total DebtLower is stronger | $282.8M | — |
| Stockholders' EquityBook value | $1.5B | $354.8M |
| Total Assets | $2.2B | $1.2B |
| Debt / EquityLower = less leverage | 0.19× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $248.6M | — | ||
| Q3 25 | $203.9M | — | ||
| Q2 25 | $188.9M | — | ||
| Q1 25 | $134.3M | $456.8M | ||
| Q4 24 | $154.6M | — | ||
| Q3 24 | $102.6M | — | ||
| Q2 24 | $87.0M | — | ||
| Q1 24 | $49.5M | — |
| Q4 25 | $282.8M | — | ||
| Q3 25 | $284.6M | — | ||
| Q2 25 | $286.4M | — | ||
| Q1 25 | $288.2M | — | ||
| Q4 24 | $290.0M | — | ||
| Q3 24 | $287.3M | — | ||
| Q2 24 | $288.0M | — | ||
| Q1 24 | $288.8M | — |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | $354.8M | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.1B | $1.2B | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — | ||
| Q1 24 | $2.1B | — |
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.20× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | 0.20× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $57.6M | $-245.6M |
| Free Cash FlowOCF − Capex | $46.6M | $-256.6M |
| FCF MarginFCF / Revenue | 12.2% | -101.6% |
| Capex IntensityCapex / Revenue | 2.9% | 4.3% |
| Cash ConversionOCF / Net Profit | 4.93× | — |
| TTM Free Cash FlowTrailing 4 quarters | $110.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.6M | — | ||
| Q3 25 | $27.3M | — | ||
| Q2 25 | $64.4M | — | ||
| Q1 25 | $-3.1M | $-245.6M | ||
| Q4 24 | $62.3M | — | ||
| Q3 24 | $22.7M | — | ||
| Q2 24 | $44.1M | — | ||
| Q1 24 | $-21.8M | — |
| Q4 25 | $46.6M | — | ||
| Q3 25 | $17.0M | — | ||
| Q2 25 | $56.6M | — | ||
| Q1 25 | $-10.3M | $-256.6M | ||
| Q4 24 | $56.0M | — | ||
| Q3 24 | $17.7M | — | ||
| Q2 24 | $39.0M | — | ||
| Q1 24 | $-26.9M | — |
| Q4 25 | 12.2% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 16.4% | — | ||
| Q1 25 | -3.1% | -101.6% | ||
| Q4 24 | 17.2% | — | ||
| Q3 24 | 5.7% | — | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | -9.0% | — |
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 2.2% | 4.3% | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | 4.93× | — | ||
| Q3 25 | 25.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.36× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFST
Segment breakdown not available.
PCLA
| Revenue from product | $179.1M | 71% |
| Revenue from SaaS, Maintenance and others | $42.4M | 17% |
| Revenue from product – related party | $31.0M | 12% |
